Rhabdomyosarcoma: Advances in Molecular and Cellular Biology

Rhabdomyosarcoma: Advances in Molecular and Cellular Biology

Rhabdomyosarcoma (RMS) is the most common soft tissue malignancy in childhood and adolescence. The two major histological subtypes of RMS are alveolar RMS, driven by the fusion protein PAX3-FKHR or PAX7-FKHR, and embryonic RMS, which is usually genetically heterogeneous. The prognosis of RMS has imp...

Full description

Bibliographic Details
Main Authors:	Xin Sun, Wei Guo, Jacson K. Shen, Henry J. Mankin, Francis J. Hornicek, Zhenfeng Duan
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	Sarcoma
Online Access:	http://dx.doi.org/10.1155/2015/232010

Similar Items

Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma
by: Pei Liu, et al.
Published: (2017-05-01)

CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma Cells
by: Tang Liu, et al.
Published: (2018-04-01)

Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway
by: Choy Edwin, et al.
Published: (2010-05-01)

Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma
by: Ryu Keinosuke, et al.
Published: (2009-11-01)

Biologic and Clinical Aspects of Rhabdomyosarcoma
by: Arya Emami, et al.
Published: (2017-03-01)

MicroRNA Involvement in Osteosarcoma
by: Eisuke Kobayashi, et al.
Published: (2012-01-01)

NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance.
by: Zhenfeng Duan, et al.
Published: (2009-10-01)

Correction to: Transcriptional activation of CBFβ by CDK11p110 is necessary to promote osteosarcoma cell proliferation
by: Yong Feng, et al.
Published: (2019-10-01)

Transcriptional activation of CBFβ by CDK11p110 is necessary to promote osteosarcoma cell proliferation
by: Yong Feng, et al.
Published: (2019-10-01)

Advances in immune checkpoint inhibitors for bone sarcoma therapy
by: Pichaya Thanindratarn, et al.
Published: (2019-04-01)

ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell lines.
by: Zhenfeng Duan, et al.
Published: (2009-09-01)

Recent Advances and Challenges in the Treatment of Rhabdomyosarcoma
by: Shinji Miwa, et al.
Published: (2020-07-01)

Plant phospholipase A: advances in molecular biology, biochemistry, and cellular function
by: Chen Guanqun, et al.
Published: (2013-10-01)

Molecular cytogenetic analysis of paediatric rhabdomyosarcoma
by: Roberts, Ian
Published: (2001)

Rhabdomyosarcoma
by: Chaudhuri P, et al.
Published: (1980-01-01)

Spectroscopic features of PHOTOGEM® in human Rhabdomyosarcoma (RD) cellular model
by: Muhammad Fakhar-e-Alam, et al.
Published: (2020-10-01)

Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.
by: Michiro Susa, et al.
Published: (2010-05-01)

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcomaResearch in context
by: Hangzhan Ma, et al.
Published: (2019-01-01)

Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordoma.
by: Linlin Zhang, et al.
Published: (2013-01-01)

Advanced Orofacial Rhabdomyosarcoma: A Retrospective Study of 31 Cases
by: Naima Otmani, et al.
Published: (2016-02-01)

Alveolar rhabdomyosarcoma: origin and prognostic implications of molecular findings
by: Pilar Eguía-Aguilar, et al.
Published: (2016-11-01)

Primary Meningeal Rhabdomyosarcoma
by: Manisha Palta, et al.
Published: (2011-01-01)

Gorlin Syndrome: Recent Advances in Genetic Testing and Molecular and Cellular Biological Research
by: Shoko Onodera, et al.
Published: (2020-10-01)

Embryonal rhabdomyosarcoma of the cervix
by: Ocheke A, et al.
Published: (2011-01-01)

Testicular fusocellular rhabdomyosarcoma as a metastasis of elbow sclerosing rhabdomyosarcoma: A clinicopathologic, immunohistochemical and molecular study of one case
by: Martorell Miguel, et al.
Published: (2010-08-01)

Rhabdomyosarcoma - site matters
by: P J Greyling, et al.
Published: (2006-02-01)

Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma
by: Hangzhan Ma, et al.
Published: (2021-02-01)

Relapsed Rhabdomyosarcoma
by: Christine M. Heske, et al.
Published: (2021-02-01)

Orbital rhabdomyosarcoma
by: Raizada I, et al.
Published: (1974-01-01)

Orbital rhabdomyosarcoma
by: I Putu Wijana, et al.
Published: (2016-10-01)

Rhabdomyosarcoma Orbita
by: Elfi Risalma Puteri, et al.
Published: (2019-09-01)

Rhabdomyosarcoma of the bladder
by: P M Deka, et al.
Published: (2001-01-01)

Alveolar Rhabdomyosarcoma
by: Kapoor Shashi, et al.
Published: (1976-01-01)

Orbital rhabdomyosarcoma
by: Misra R
Published: (1971-01-01)

Rhabdomyosarcoma of the kidney
by: Alaa Samkari, et al.
Published: (2018-05-01)

Cardiac rhabdomyosarcoma
by: Damjanović Miodrag R., et al.
Published: (2007-01-01)

Embryonal Rhabdomyosarcoma
by: Halder Saswati, et al.
Published: (2001-01-01)

Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: Utility and pitfalls
by: Ashley R.P. Hinson, et al.
Published: (2013-07-01)

Coronaviruses: Molecular and Cellular Biology
by: Julian L. Leibowitz
Published: (2008-04-01)

The role of extracelluar matrix in osteosarcoma progression and metastasis
by: Juncheng Cui, et al.
Published: (2020-09-01)

Cannot write session to /tmp/vufind_sessions/sess_9glk6qh99j1a4hn2akjm5gqe24